Winselow Tucker joins Eli Lilly at the end of August as Senior Vice President and Chief Commercial Officer for Loxo@Lilly, reporting to Jacob Van Naarden, senior vice president and CEO of Loxo@Lilly.
Winselow joins Lilly from Bristol Myers Squibb, where he served as senior vice president and general manager of US Hematology before assuming his current responsibilities as senior vice president, intercontinental, earlier this year. Prior to joining BMS, Winselow held leadership roles at Novartis and Celgene. He holds a bachelor’s degree in business administration from Howard University and a Master of Business Administration from Indiana University.
“Winselow brings deep expertise in both oncology and hematology that will support the continued growth of our existing commercial portfolio and efforts to bring our pipeline of cancer medicines to patients around the world,” said Van Naarden.
